Pharmaceuticals 
This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Find the best Christmas presents and January Sales in the UK with this simple shopping directory.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 37.
Massachusetts Health Plan Harvard Pilgrim Signs On With Castlight Health
In 2008, Castlight Health took on the formidable task of unmasking health care costs so that companies and their employees can make informed decisions, based on price as well as quality. Those prices, often shrouded in secrecy, are mostly the result of negotiations between insurers and health care providers, and can vary widely even within the same city.
Source: Forbes.com Healthcare News - January 31, 2013 Category: Pharmaceuticals Authors: Zina Moukheiber Source Type: news
Pfizer Wins RAPAMUNE Patent Case in Delaware District Court
NEW YORK--(BUSINESS WIRE)--Jan 31, 2013 - Pfizer Inc. said today
that the United States District Court for the District of Delaware
ruled that Pfizer's patent covering a method for using sirolimus,
the active ingredient in RAPAMUNE®, for the...
Source: Drugs.com - Pharma News - January 31, 2013 Category: Pharmaceuticals Source Type: news
Part 2: Does Massachusetts Predict Employer Behavior Under Obamacare? Probably Not
Yesterday, we examined two reasons why the Massachusetts health reform law is unlikely to predict employer behavior under Obamacare.
Source: Forbes.com Healthcare News - January 31, 2013 Category: Pharmaceuticals Authors: Josh Archambault Source Type: news
Outsource Or Manage Internally? Pharma Logistics, 9-10 April 2013, Vienna, Austria
"The current trend in pharma logistics is the shift from blockbuster drugs. 6 out of 10 top selling drugs will lose their patents in one year, so there will be increase in the use of generic drugs," Sebastiaan Scholte, Chairman at Cool Chain Association, pointed out when speaking about the latest developments. These trends influence drug manufacturers and make them rethink their strategies. Already without medications like Lipitor and Plavix bolstering their bottom lines, manufacturers have to cut costs in order to stay competitive...
Source: Health News from Medical News Today - January 31, 2013 Category: Consumer Health News Tags: Conferences Source Type: news
Are Republicans Bigger Spenders Than Democrats?
Overspending isn’t a problem exclusive to one political party or another. All you need do is observe the differences between the restraint witnessed under the Reagan and Clinton administrations and the excess of those of Bush and Obama to see that the public must keep close watch the government’s purse strings regardless of who’s residing at 1600 Pennsylvania Avenue. However, the political aisle may play a distinguish role in spending when it comes to Capitol Hill.
Source: Forbes.com Healthcare News - January 31, 2013 Category: Pharmaceuticals Authors: Chris Conover Source Type: news
Is Innovation In Chromatography Losing Steam?
BIO innovation notes -Both end users and vendors are investing less.
Source: Pharmaceutical Online News - January 31, 2013 Category: Pharmaceuticals Source Type: news
Lonza Joins Roundtable on Sustainable Palm Oil
Lonza today announced membership in the Roundtable on Sustainable Palm Oil (RSPO), an international organisation of growers, processors, traders, non-governmental organisations, investors, retailers and consumer goods manufactures working together to…
Source: Pharmaceutical Technology - January 31, 2013 Category: Pharmaceuticals Source Type: news
Observational study suggests a role for Ferinject®
On the eve of World Cancer Day, Vifor Pharma notes the publication of an observational study in routine oncological and haematological settings encompassing anaemic and iron-deficient patients with a wide variety of tumours
Source: Pharmacy Europe - January 31, 2013 Category: Drugs & Pharmacology Source Type: news
AstraZeneca warns of tough year ahead
Increased competition from generics and the failure of developmental treatments hits 2012 profits at the Anglo-Swedish drugmaker
Source: FT.com - Drugs and Healthcare - January 31, 2013 Category: Pharmaceuticals Source Type: news
Patheon To Present At ExL Pharma's 2nd Enhancing Drug Bioavailability And Solubility Conference
A presentation “Solid Dispersion Techniques for Enhancing Solubility” will be given by Jason M. Vaughn, Ph.D., Director, Formulations and Process Development, Pharmaceutical Development Services, Patheon Inc. on Tuesday, January 22, 2013 at 4:10 p.m. Eastern Time.
Source: Pharmaceutical Online News - January 31, 2013 Category: Pharmaceuticals Source Type: news
Feature Story: Why Animal Health Matters
Whether you have two legs, four legs, wings, tail or fins, health issues arise. Merck is committed to addressing unmet medical needs in both humans and animals.
Source: Merck.com - Feature Stories About Merck - January 31, 2013 Category: Pharmaceuticals Source Type: news
Feature Story: Go Red For Women
Are you at risk for heart disease? It's the number one killer of women, yet only one in five American women believes that heart disease is their greatest threat.
Source: Merck.com - Feature Stories About Merck - January 31, 2013 Category: Pharmaceuticals Source Type: news
Obinutuzumab (GA101) significantly improved progression-free survival in people with chronic lymphocytic leukemia (CLL)
Roche today announced positive results from stage 1 of CLL11, a phase III randomised study to investigate the efficacy and safety profile of the investigational medicine obinutuzumab (GA101) plus chlorambucil, a chemotherapy, compared with chlorambucil alone in people with previously untreated chronic lymphocytic leukemia (CLL). An improvement in progression-free survival (PFS) was achieved: GA101 plus chlorambucil significantly reduced the risk of disease worsening or death compared to chlorambucil alone.
Source: Roche Investor Update - January 31, 2013 Category: Pharmaceuticals Source Type: news
Teva Announces Termination Of Agreements With Curetech
Teva Pharmaceutical Industries Ltd. announced recently the termination of its collaboration with CureTech Ltd.
Source: Pharmaceutical Online News - January 31, 2013 Category: Pharmaceuticals Source Type: news
Health Subsidies Won't Cover Some Low Earners
Workers' dependents who face high premiums for employer-sponsored family insurance plans won't be eligible for tax subsidies to help them buy their own policies under the health overhaul.
Source: WSJ.com: Health - January 31, 2013 Category: Pharmaceuticals Tags: PAID Source Type: news
RYZOLT (Tramadol Hydrochloride) Tablet, Extended Release [Purdue Pharma LP]
Updated Date: Jan 31, 2013 EST
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - January 31, 2013 Category: Drugs & Pharmacology Source Type: news
Can A Rose Catch Your Cold? Threat Of 'Killer' Viral Plant Gene Is Latest Anti-GMO Rant
As the Genetic Literacy Project’s Jon Entine reports, genetic science deniers like the Organic Consumers Association, the Institute for Responsible Technology and many organizations that describe themselves as ‘progressive’ are again loudly ringing the anti-genetically modified organism fear-and-panic bell.
Source: Forbes.com Healthcare News - January 30, 2013 Category: Pharmaceuticals Authors: Jon Entine Source Type: news
Some Unions Wary of Health Law They Backed
Labor unions enthusiastically backed the Obama administration's health-care overhaul when it was up for debate. Now that the law is rolling out, some are turning sour.
Source: WSJ.com: Health - January 30, 2013 Category: Pharmaceuticals Tags: PAID Source Type: news
Monthly News Round Up - January 2013
Genzyme’s Kynamro Approved to Treat Inherited Cholesterol Disorder
The U.S. Food and Drug Administration has approved Kynamro (mipomersen sodium) injection, an orphan drug used to treat patients with a rare and often fatal type of high...
Source: Drugs.com - Pharma News - January 30, 2013 Category: Pharmaceuticals Source Type: news
Tapemark Expands Capabilities For Transdermal Patches
Tapemark is pleased to announce the addition of several new capabilities for transdermal patches, including the formulation, blending, and coating steps in the patch manufacturing process.
Source: Pharmaceutical Online News - January 30, 2013 Category: Pharmaceuticals Source Type: news
Galapagos Receives EUR2.5 Million IWT Grant For IBD Research
Galapagos NV (Euronext: GLPG) announced today that it has been awarded a EUR2.5 million grant from the Flemish agency for Innovation by Science and Technology (IWT) for inflammatory bowel disease (IBD) research and development. The goal of this 2.5-year project is to identify new therapeutic compounds for future treatment of IBD patients.
Source: Pharmaceutical Online News - January 30, 2013 Category: Pharmaceuticals Source Type: news
AbbVie Issues Inaugural Full-Year Outlook For 2013
AbbVie today confirmed it delivered strong sales growth with its marketed pharmaceutical products in 2012. The proprietary pharmaceutical segment of Abbott, representing the majority of AbbVie's revenue, grew more than 8 percent globally on an operational basis, excluding a nearly 3 percent negative impact from foreign exchange.
Source: Pharmaceutical Online News - January 30, 2013 Category: Pharmaceuticals Source Type: news
FDA Approves New Orphan Drug Kynamro To Treat Inherited Cholesterol Disorder
The U.S. Food and Drug Administration recently approved Kynamro (mipomersen sodium) injection as an addition to lipid-lowering medications and diet to treat patients with a rare type of high cholesterol called homozygous familial hypercholesterolemia (HoFH).
Source: Pharmaceutical Online News - January 30, 2013 Category: Pharmaceuticals Source Type: news
Yusen Logistics' Pharma Superhighway Set To Pass Million Pallet Milestone In 2013
Yusen Logistics’ European Pharmaceutical Superhighway is contracted to carry over one million pallets this year, providing solutions to highly complex supply chain requirements for both major global manufacturers and small biotech companies.
Source: Pharmaceutical Online News - January 30, 2013 Category: Pharmaceuticals Source Type: news
Morning-after pill conscience clause should be banned, say pharmacists
The conscience clause that allows pharmacists to opt-out of providing the morning-after pill without a prescription should be banned or a clearer stance taken, according to pharmacists writing in the Journal of Medical Ethics.
Source: Pharmaceutical Technology - January 30, 2013 Category: Pharmaceuticals Source Type: news
France suspends Bayer’s Diane-35 sales after deaths
The French medicines agency (ANSM) said it will suspend sales of Bayer's acne pill Diane-35 and its generics after it was confirmed that four deaths in the last 25 years were linked to its use.
Source: Pharmaceutical Technology - January 30, 2013 Category: Pharmaceuticals Source Type: news
Anacor reports positive preliminary results from tavaborole Phase III onychomycosis trial
Biopharmaceutical company Anacor Pharmaceuticals has reported positive preliminary results from the first of two Phase III trials of topical anti-fungal tavaborole, designed to treat onychomycosis.
Source: Drug Development Technology - January 30, 2013 Category: Pharmaceuticals Source Type: news
FDA approves Kynamro injection for homozygous familial hypercholesterolemia
The US FDA has approved orphan drug Kynamro (mipomersen sodium) injection for the treatment of homozygous familial hypercholesterolemia (HoFH), an inherited cholesterol disorder.
Source: Drug Development Technology - January 30, 2013 Category: Pharmaceuticals Source Type: news
'Canary In The Trousers': Why Erectile Dysfunction Can Signal Heart Disease
Erection problems seem to be a good predictor of heart disease. Take them seriously.
Source: Forbes.com Healthcare News - January 30, 2013 Category: Pharmaceuticals Authors: Alice G. Walton Source Type: news
Adopting Orphan Drugs
Rare diseases, once the neglected stepchild of drug makers, are receiving booming interest from the industry.
Source: WSJ.com: Health - January 30, 2013 Category: Pharmaceuticals Tags: PAID Source Type: news
Small Study Suggests Yoga May Benefit People With Irregular Heartbeats
Source: Forbes.com Healthcare News - January 30, 2013 Category: Pharmaceuticals Authors: Larry Husten Source Type: news
The STAT Ten: Eric Topol, MD Speaks Out on Digital Health
The trajectory of digital health is, in part, driven by Eric Topol. A cardiologist, Chief Academic Officer of Scripps Health in San Diego, author (The Creative Destruction of Medicine) and futurist, Dr. Topol provides some of the essential "glue" to this important health movement. His voice is clear and resonant and I recently served up 10 quick question to get his up-to-date perspective on digital health.
Source: Forbes.com Healthcare News - January 30, 2013 Category: Pharmaceuticals Authors: John Nosta Source Type: news
Bayer Faces Halt to Acne-Drug Sales
France's drug watchdog said it is taking steps to halt sales of an acne treatment that is widely used as a contraceptive, after the drug—made by Bayer—was linked to four deaths over the past 25 years.
Source: WSJ.com: Health - January 30, 2013 Category: Pharmaceuticals Tags: PAID Source Type: news
Five Reasons Why Tesco's Horse Meat Scandal Could Happen Here
The Tesco horse meat scandal could play out in rural America if a new bill to overturn Oklahoma's 1963 ban on slaughtering horses succeeds.
Source: Forbes.com Healthcare News - January 30, 2013 Category: Pharmaceuticals Authors: Vickery Eckhoff Source Type: news
Mayo Clinic to Invest More than $3 Billion to Position Minn. as World Destination for Health Care
Mayo Clinic today announced Destination Medical Center (DMC), a $5 billion economic development initiative to secure Minnesota's status as a global medical destination center now and in the future.
Source: Mayo Clinic Business News - January 30, 2013 Category: Pharmaceuticals Authors: Mayo Clinic Source Type: news
inVentiv Health Launches "Done as One" Integrated Services Model to Better Meet Global Demand for Unified Healthcare Communications Expertise
Model Offers Clients Instant Access to a Whole New Level of
Collaboration Among Communications Disciplines Around the
World
BURLINGTON, Mass., Jan. 29, 2013 /PRNewswire/ -- inVentiv
Health, Inc., offering best-in-class clinical, commercial...
Source: Drugs.com - Pharma News - January 30, 2013 Category: Pharmaceuticals Source Type: news
FDA cites Novo for 850 infractions spanning 2 years
The FDA posted a scathing warning letter sent in December to Novo Nordisk about a plant in Novo Alle, Bagsvaerd, Denmark. The FDA says that over two years the plant failed to collect nearly 850 samples for environmental testing. The Swedish insulin specialist could not be reached for comment, but in issuing its earnings report recently it acknowledged the letter and said, "Novo Nordisk does not expect the letter to have an impact on products currently marketed in the U.S."
Source: PharmaManufacturing.com - January 30, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news
Quantifying Humidity's Impact on Powder Processing
Dynamic test methods assess moisture to improve process understanding and development
Source: PharmaManufacturing.com - January 30, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news
A Culture of Innovation: A Q&A with Jeffrey S. Hatfield, CEO of Vitae Pharmaceuticals
In this Q&A with Lisa Walkush, principal with Grant Thornton LLP's Life Sciences practice, CEO of Vitae Pharmaceuticals Jeffrey S. Hatfield covers his emerging company and the changes to the industry.
Source: PharmaManufacturing.com - January 30, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news
Strength in Unity: The Case for Global Supply Chain Standards
Agreement around common supply chain standards and supporting processes could revolutionize the healthcare sector
Source: PharmaManufacturing.com - January 30, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news
Funny Pharm: You Write the Caption & Win: February 2013
"Funny Pharm," features drawings by award-winning cartoonist Jerry King. Submit your caption and win
Source: PharmaManufacturing.com - January 30, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news
America's Top 20 Healthiest Cities
If an active and healthful lifestyle is what you seek, head to these fit locales.
Source: Forbes.com Healthcare News - January 30, 2013 Category: Pharmaceuticals Authors: Alice G. Walton Source Type: news
DOJ/FDA Brief in SCOTUS Generic Drug Preemption Case Hands Plaintiffs New Liability Theories
During the last four years, the Food and Drug Administration has been a faithful ally of the plaintiffs’ bar, routinely opposing any suggestion that federal approval of a prescription drug preempts a state-law tort claim against the drug’s manufacturer. That’s why it came as surprise to some when last week the United States filed an amicus curiae brief urging the Supreme Court to rule in Mutual Pharmaceutical Co. v. Bartlett that federal law preempts design-defect claims against the manufacturer of a generic drug. The plaintiffs’ bar need not worry, however; the amicus brief set out a detailed roadmap t...
Source: Forbes.com Healthcare News - January 30, 2013 Category: Pharmaceuticals Authors: Rich Samp Source Type: news
GSK response to news article in The Guardian on UK legal proceedings related to Avandia (rosiglitazone)
Source: GSK news - January 30, 2013 Category: Pharmaceuticals Source Type: news
AbbVie CEO Says Humira Will Blunt $1B Hit To Lipid Franchise
The former proprietary drug business of Abbott Laboratories (ABT), now split off into AbbVie (ABBV), expects to continue to benefit from the robust growth of its Humira biologic for myriad autoimmune diseases.
Source: Forbes.com Healthcare News - January 30, 2013 Category: Pharmaceuticals Authors: Bruce Japsen Source Type: news
Biotech M&A in 2012: The Good, Bad, and Ugly
The numbers are in on the 2012 Pharma/Biotech M&A performance, at least according to our friends at HBM Partners. They’ve released another well-annotated deal report and database.
Source: Forbes.com Healthcare News - January 30, 2013 Category: Pharmaceuticals Authors: Bruce Booth Source Type: news
GEOSENTRIC SIGNS TERM SHEET ON ACQUIRING NEW BUSINESS
GEOSENTRIC OYJ STOCK EXCHANGE RELEASE January 30, 2013 at 16:15
GEOSENTRIC SIGNS TERM SHEET ON ACQUIRING NEW BUSINESS
GeoSentric Oyj announces the signing of a term sheet regarding the acquisition
of Sinophi Healthcare Limited, a company operating in the field of private
specialty healthcare, especially in China. The Sinophi business is focused on
leveraging its healthcare platform of hospital management, pharmacy outsourcing
and the provision of hospital supplies. The tra
Source: Medical News (via PRIMEZONE) - January 30, 2013 Category: Pharmaceuticals Source Type: news
Diana Containerships Inc. Announces the Date for the 2012 Fourth Quarter and Year-End Financial Results, Conference Call and Webcast
ATHENS, Greece, Jan. 30, 2013 (GLOBE NEWSWIRE) -- Diana Containerships Inc. (Nasdaq:DCIX), a global shipping company specializing in owning and operating containerships, today announced that its financial results for the fourth quarter and year ended December 31, 2012 are scheduled to be released before the opening of the U.S. financial markets on Tuesday, February 19, 2013.
Source: Medical News (via PRIMEZONE) - January 30, 2013 Category: Pharmaceuticals Source Type: news
Novo Nordisk A/S - Share repurchase programme
[HUG#1674224]
Source: Medical News (via PRIMEZONE) - January 30, 2013 Category: Pharmaceuticals Source Type: news
